Naturally gluten-free foods
Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis
Shingrix shingles vaccine linked with lower heart disease risks
Estrogen-only hormone therapy tied to lower dementia risk
Should you have a hysterectomy?
Stair climbing may significantly lower cardiovascular risks
Why do I sweat so much?
Walking pneumonia: The "mild" illness that can still pack a punch
What causes knee pain: How doctors make a diagnosis
Where you carry excess weight matters in predicting heart disease risk
Adam S. Cheifetz, MD
Contributor
Dr. Adam Cheifetz is director of the center for inflammatory bowel disease and medical director of infusion services at Beth Israel Deaconess Medical Center, and professor of medicine at Harvard Medical School. He is a well-recognized leader in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. He is involved in multiple research projects relating to IBD, and has published over 200 articles and chapters on the subject.
His research currently focuses on therapeutic drug monitoring and optimizing the use of biologics through the proactive use of drug concentrations and antibodies, and he has published extensively in this area. Dr. Cheifetz was the first to demonstrate that proactive monitoring of infliximab and adalimumab concentrations and dosing to a therapeutic window improves outcomes when compared to standard of care.
Naturally gluten-free foods
Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis
Shingrix shingles vaccine linked with lower heart disease risks
Estrogen-only hormone therapy tied to lower dementia risk
Should you have a hysterectomy?
Stair climbing may significantly lower cardiovascular risks
Why do I sweat so much?
Walking pneumonia: The "mild" illness that can still pack a punch
What causes knee pain: How doctors make a diagnosis
Where you carry excess weight matters in predicting heart disease risk
